Cooperative Research Centre for Cancer Therapeutics

Canthera Discovery, formerly known as the Cooperative Research Centre for Cancer Therapeutics (CTx), is an Australian drug discovery and development organization focused on translating high-quality academic research into novel cancer therapies. Operating as a collaborative consortium, it integrates expertise from leading medical research institutes and universities with industrial-scale drug discovery capabilities. The organization specializes in the development of small molecule inhibitors, particularly in the fields of epigenetics and kinase signaling. Canthera has achieved significant commercial success, including major licensing agreements with global pharmaceutical leaders such as Merck & Co. and Pfizer. By bridging the gap between laboratory discovery and clinical development, Canthera aims to provide new treatment options for patients with hard-to-treat cancers.